anti-GABPB2 antibody product blog
Tags: Antibody; Monoclonal Antibody; GABPB2; anti-GABPB2 antibody;
The GABPB2 n/a (Catalog #MBS5306135) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s GABPB2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB). Researchers should empirically determine the suitability of the GABPB2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The GABPB2 n/a product has the following accession number(s) (GI #649114189) (NCBI Accession #AIC53004.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Mouse monoclonal GABPB2 antibody with the following immunoassay(s):
Western Blot (WB) (Western blot (1:500) analysis of GABPB2 expression in Jurkat whole cell lysate with GABPB2 antibody)
Immunogen: GABPB2 antibody was raised in Mouse using a synthetic peptide (KLH-coupled) corresponding to the residues of GABPB2 protein as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing GABPB2 are readily searchable from our website. Different antibodies against the same target such as GABPB2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.